These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 8788116

  • 21. Effect of lithium in immunodeficiency: improved blood cell formation in mice with decreased hematopoiesis as the result of LP-BM5 MuLV infection.
    Gallicchio VS, Hughes NK, Tse KF, Ling J, Birch NJ.
    Antiviral Res; 1995 Mar; 26(2):189-202. PubMed ID: 7605115
    [Abstract] [Full Text] [Related]

  • 22. Secondary cytokines interact in sequence with interleukin-1alpha (IL-1alpha) with or without macrophage colony-stimulating factor (M-CSF) to further accelerate granulopoietic recovery in myelosuppressed animals.
    Kovacs CJ, Evans MJ, Daly BM, Thomas-Patterson D, Johnke RM, Powell DS.
    J Interferon Cytokine Res; 1997 Aug; 17(8):453-60. PubMed ID: 9282825
    [Abstract] [Full Text] [Related]

  • 23. Sensitivity of erythroid progenitor colonies to erythropoietin in azidothymidine treated immunodeficient mice.
    Chow FP, Sutton PA, Hamburger AW.
    Br J Haematol; 1991 Feb; 77(2):139-44. PubMed ID: 2004015
    [Abstract] [Full Text] [Related]

  • 24. Modulation of murine hematopoiesis in vivo with recombinant murine interleukin-1.
    Gallicchio VS, Shedlofsky SI, Swim AT, Robinson JM, Hulette BC, Messino MJ, Doukas MA.
    J Biol Response Mod; 1989 Aug; 8(4):422-39. PubMed ID: 2666587
    [Abstract] [Full Text] [Related]

  • 25. Increased granulopoiesis after sequential administration of transforming growth factor-beta 1 and granulocyte-macrophage colony-stimulating factor.
    Hestdal K, Jacobsen SE, Ruscetti FW, Longo DL, Boone TC, Keller JR.
    Exp Hematol; 1993 Jun; 21(6):799-805. PubMed ID: 8500577
    [Abstract] [Full Text] [Related]

  • 26. Effects of combinations of stem cell factor and hemin on erythropoiesis after azidothymidine treatment of immunosuppressed mice.
    Hamburger AW.
    Eur J Haematol; 1996 Aug; 57(2):128-33. PubMed ID: 8856089
    [Abstract] [Full Text] [Related]

  • 27. In-vivo effect of interleukin 3 and erythropoietin, either alone or in combination, on the hematopoietic toxicity associated with zidovudine.
    Gallicchio VS, Hughes NK, Tse KF.
    Cytokine; 1993 Jan; 5(1):62-71. PubMed ID: 8485306
    [Abstract] [Full Text] [Related]

  • 28. The relationship between different high proliferative potential colony-forming cells in mouse bone marrow.
    Kriegler AB, Verschoor SM, Bernardo D, Bertoncello I.
    Exp Hematol; 1994 May; 22(5):432-40. PubMed ID: 7513652
    [Abstract] [Full Text] [Related]

  • 29. Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells.
    Muench MO, Schneider JG, Moore MA.
    Exp Hematol; 1992 Mar; 20(3):339-49. PubMed ID: 1373685
    [Abstract] [Full Text] [Related]

  • 30. The in vitro effect of high-dose recombinant human erythropoietin on granulocyte-macrophage colony production in premature infants using a defined serum deprived cell culture system.
    Ward CS, Westwood NB, Emmerson AJ, Pearson TC.
    Br J Haematol; 1992 Jul; 81(3):325-30. PubMed ID: 1382542
    [Abstract] [Full Text] [Related]

  • 31. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 32. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
    Atkinson K, Vos B, Kang-Er Z, Guiffre A, Seymour R, Gillis S.
    Cytokines Mol Ther; 1995 Mar; 1(1):47-55. PubMed ID: 9384663
    [Abstract] [Full Text] [Related]

  • 33. Effect of blood substitute, recombinant hemoglobin, on in vivo hematopoietic recovery from AZT toxicity.
    Moqattash S, Lutton JD, Rosenthal G, Abu-Hijleh MF, Abraham NG.
    Acta Haematol; 1997 Mar; 98(2):76-82. PubMed ID: 9286303
    [Abstract] [Full Text] [Related]

  • 34. Induction of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) expression in bone marrow and fractionated marrow cell populations by interleukin 3 (IL-3): IL-3-mediated positive feedback mechanisms of granulopoiesis.
    Tsuji T, Sugimoto K, Yanai T, Takashita E, Mori KJ.
    Growth Factors; 1994 Mar; 11(1):71-9. PubMed ID: 7530467
    [Abstract] [Full Text] [Related]

  • 35. Interaction of granulocyte-macrophage colony-stimulating factor and interleukin 3 in human long-term bone marrow culture.
    Gibson FM, Bagnara M, Ioannidou E, Gordon-Smith EC.
    Exp Hematol; 1992 Feb; 20(2):235-40. PubMed ID: 1544393
    [Abstract] [Full Text] [Related]

  • 36. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors.
    Broxmeyer HE, Williams DE, Hangoc G, Cooper S, Gentile P, Shen RN, Ralph P, Gillis S, Bicknell DC.
    Blood Cells; 1987 Feb; 13(1-2):31-48. PubMed ID: 3499193
    [Abstract] [Full Text] [Related]

  • 37. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Gibson FM, Scopes J, Daly S, Ball SE, Gordon-Smith EC.
    Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
    [Abstract] [Full Text] [Related]

  • 38. Regulation of megakaryocyte colony forming cell numbers and ploidy by dideoxynucleosides in immunodeficient mice.
    Chow FP, Ordóñez JV, Sutton PA, Hamburger AW.
    Am J Hematol; 1993 Dec; 44(4):249-55. PubMed ID: 8237995
    [Abstract] [Full Text] [Related]

  • 39. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 40. Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection.
    Pluda JM, Yarchoan R, Smith PD, McAtee N, Shay LE, Oette D, Maha M, Wahl SM, Myers CE, Broder S.
    Blood; 1990 Aug 01; 76(3):463-72. PubMed ID: 2198957
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.